AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression

Summary

The study will evaluate the safety and efficacy of AV-101.

Timeline

Start

2018-03-05

Primary completion

2019-10-01

Completion

2019-10-01

Publications

• Patel W, Shankar RG, Smith MA, Snodgrass HR, Pirmohamed M, Jorgensen AL, Alfirevic A, Dickens D. Role of Transporters and Enzymes in Metabolism and Distribution of 4-Chlorokynurenine (AV-101). Mol Pharm. 2024 Feb 5;21(2):550-563. doi: 10.1021/acs.molpharmaceut.3c00700. Epub 2024 Jan 23.

Drugs

Indications